ID   FADS1_HUMAN             Reviewed;         444 AA.
AC   O60427; A8K0I7; B2RAI0; Q53GM5; Q8N3A6; Q8NCC7; Q8NCG0; Q96I39; Q96SV3;
AC   Q96T10; Q9NRP8; Q9NYX1;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-DEC-2013, sequence version 3.
DT   18-JUN-2025, entry version 194.
DE   RecName: Full=Acyl-CoA (8-3)-desaturase {ECO:0000305};
DE            EC=1.14.19.44 {ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175};
DE   AltName: Full=Delta(5) fatty acid desaturase;
DE            Short=D5D {ECO:0000250|UniProtKB:Q920L1};
DE            Short=Delta(5) desaturase {ECO:0000250|UniProtKB:Q920L1};
DE            Short=Delta-5 desaturase {ECO:0000303|PubMed:10601301, ECO:0000303|PubMed:10769175};
DE   AltName: Full=Fatty acid desaturase 1 {ECO:0000303|PubMed:10860662};
GN   Name=FADS1 {ECO:0000303|PubMed:10860662, ECO:0000312|HGNC:HGNC:3574};
GN   Synonyms=FADSD5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=10601301; DOI=10.1074/jbc.274.52.37335;
RA   Cho H.P., Nakamura M., Clarke S.D.;
RT   "Cloning, expression, and fatty acid regulation of the human Delta-5
RT   desaturase.";
RL   J. Biol. Chem. 274:37335-37339(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   CATALYTIC ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=10769175; DOI=10.1042/bj3470719;
RA   Leonard A.E., Kelder B., Bobik E.G., Chuang L.-T., Parker-Barnes J.M.,
RA   Thurmond J.M., Kroeger P.E., Kopchick J.J., Huang Y.-S., Mukerji P.;
RT   "cDNA cloning and characterization of human Delta5-desaturase involved in
RT   the biosynthesis of arachidonic acid.";
RL   Biochem. J. 347:719-724(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=10860662; DOI=10.1006/geno.2000.6196;
RA   Marquardt A., Stoehr H., White K., Weber B.H.;
RT   "cDNA cloning, genomic structure, and chromosomal localization of three
RT   members of the human fatty acid desaturase family.";
RL   Genomics 66:175-183(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, Neuroblastoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney epithelium;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-272.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SUBCELLULAR LOCATION (ISOFORM 1), AND INDUCTION.
RX   PubMed=22619218; DOI=10.1194/jlr.m025312;
RA   Park W.J., Kothapalli K.S., Reardon H.T., Lawrence P., Qian S.B.,
RA   Brenna J.T.;
RT   "A novel FADS1 isoform potentiates FADS2-mediated production of eicosanoid
RT   precursor fatty acids.";
RL   J. Lipid Res. 53:1502-1512(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   ACETYLATION AT MET-1.
RX   PubMed=25732826; DOI=10.1016/j.celrep.2015.01.053;
RA   Aksnes H., Van Damme P., Goris M., Starheim K.K., Marie M., Stoeve S.I.,
RA   Hoel C., Kalvik T.V., Hole K., Glomnes N., Furnes C., Ljostveit S.,
RA   Ziegler M., Niere M., Gevaert K., Arnesen T.;
RT   "An organellar nalpha-acetyltransferase, naa60, acetylates cytosolic N
RT   termini of transmembrane proteins and maintains Golgi integrity.";
RL   Cell Rep. 10:1362-1374(2015).
CC   -!- FUNCTION: [Isoform 1]: Acts as a front-end fatty acyl-coenzyme A (CoA)
CC       desaturase that introduces a cis double bond at carbon 5 located
CC       between a preexisting double bond and the carboxyl end of the fatty
CC       acyl chain. Involved in biosynthesis of highly unsaturated fatty acids
CC       (HUFA) from the essential polyunsaturated fatty acids (PUFA) linoleic
CC       acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3)
CC       precursors. Specifically, desaturates dihomo-gamma-linoleoate (DGLA)
CC       (20:3n-6) and eicosatetraenoate (ETA) (20:4n-3) to generate
CC       arachidonate (AA) (20:4n-6) and eicosapentaenoate (EPA) (20:5n-3),
CC       respectively (PubMed:10601301, PubMed:10769175). As a rate limiting
CC       enzyme for DGLA (20:3n-6) and AA (20:4n-6)-derived eicosanoid
CC       biosynthesis, controls the metabolism of inflammatory lipids like
CC       prostaglandin E2, critical for efficient acute inflammatory response
CC       and maintenance of epithelium homeostasis. Contributes to membrane
CC       phospholipid biosynthesis by providing AA (20:4n-6) as a major acyl
CC       chain esterified into phospholipids. In particular, regulates
CC       phosphatidylinositol-4,5-bisphosphate levels, modulating inflammatory
CC       cytokine production in T-cells (By similarity). Also desaturates (11E)-
CC       octadecenoate (trans-vaccenoate)(18:1n-9), a metabolite in the
CC       biohydrogenation pathway of LA (18:2n-6) (By similarity).
CC       {ECO:0000250|UniProtKB:Q920L1, ECO:0000250|UniProtKB:Q920R3,
CC       ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175}.
CC   -!- FUNCTION: [Isoform 2]: Does not exhibit any catalytic activity toward
CC       20:3n-6, but it may enhance FADS2 activity.
CC       {ECO:0000250|UniProtKB:A4UVI1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z)-eicosatrienoyl-CoA + 2 Fe(II)-[cytochrome b5] +
CC         O2 + 2 H(+) = (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 2 Fe(III)-
CC         [cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:46424, Rhea:RHEA-COMP:10438,
CC         Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:57368, ChEBI:CHEBI:74264; EC=1.14.19.44;
CC         Evidence={ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46425;
CC         Evidence={ECO:0000305|PubMed:10601301};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA + 2 Fe(II)-[cytochrome
CC         b5] + O2 + 2 H(+) = (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl-CoA + 2
CC         Fe(III)-[cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:46420, Rhea:RHEA-
CC         COMP:10438, Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:29033,
CC         ChEBI:CHEBI:29034, ChEBI:CHEBI:73862, ChEBI:CHEBI:74265;
CC         EC=1.14.19.44; Evidence={ECO:0000269|PubMed:10769175};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46421;
CC         Evidence={ECO:0000305|PubMed:10769175};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11E)-octadecenoyl-CoA + 2 Fe(II)-[cytochrome b5] + O2 + 2
CC         H(+) = (5Z,11E)-octadecadienoyl-CoA + 2 Fe(III)-[cytochrome b5] + 2
CC         H2O; Xref=Rhea:RHEA:46060, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:74296,
CC         ChEBI:CHEBI:85651; Evidence={ECO:0000250|UniProtKB:Q920R3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46061;
CC         Evidence={ECO:0000250|UniProtKB:Q920R3};
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A4UVI1}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A4UVI1}. Mitochondrion
CC       {ECO:0000269|PubMed:22619218}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A4UVI1}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A4UVI1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=FADS1CS;
CC         IsoId=O60427-1; Sequence=Displayed;
CC       Name=2; Synonyms=FADS1AT1;
CC         IsoId=O60427-2; Sequence=VSP_047521;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in liver,
CC       brain, adrenal gland and heart. Highly expressed in fetal liver and
CC       brain. {ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175,
CC       ECO:0000269|PubMed:10860662}.
CC   -!- INDUCTION: Strongly down-regulated upon differentiation in a
CC       neuroblastoma cell line (at protein level).
CC       {ECO:0000269|PubMed:22619218}.
CC   -!- DOMAIN: The histidine box domains may contain the active site and/or be
CC       involved in metal ion binding.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11182.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC11229.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK027427; BAB55103.1; -; mRNA.
DR   EMBL; AK027522; BAB55173.1; -; mRNA.
DR   EMBL; AK074754; BAC11182.1; ALT_INIT; mRNA.
DR   EMBL; AK074819; BAC11229.1; ALT_INIT; mRNA.
DR   EMBL; AK096275; BAG53244.1; -; mRNA.
DR   EMBL; AK289552; BAF82241.1; -; mRNA.
DR   EMBL; AK314199; BAG36877.1; -; mRNA.
DR   EMBL; AC004770; AAC23397.1; -; Genomic_DNA.
DR   EMBL; AP002380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF084558; AAG23120.1; -; mRNA.
DR   EMBL; AL512760; CAC21679.1; -; mRNA.
DR   EMBL; AL834479; CAD39138.1; -; mRNA.
DR   EMBL; AK222906; BAD96626.1; -; mRNA.
DR   EMBL; BC007846; AAH07846.1; -; mRNA.
DR   EMBL; AF199596; AAF29378.1; -; mRNA.
DR   EMBL; AF226273; AAF70457.1; -; mRNA.
DR   RefSeq; NP_037534.3; NM_013402.4.
DR   RefSeq; XP_047282891.1; XM_047426935.1. [O60427-2]
DR   RefSeq; XP_054224724.1; XM_054368749.1. [O60427-2]
DR   AlphaFoldDB; O60427; -.
DR   SMR; O60427; -.
DR   BioGRID; 110180; 94.
DR   FunCoup; O60427; 1320.
DR   IntAct; O60427; 63.
DR   MINT; O60427; -.
DR   STRING; 9606.ENSP00000322229; -.
DR   BindingDB; O60427; -.
DR   ChEMBL; CHEMBL5840; -.
DR   DrugBank; DB00132; alpha-Linolenic acid.
DR   DrugBank; DB11358; Evening primrose oil.
DR   DrugBank; DB00159; Icosapent.
DR   DrugBank; DB13168; Omega-6 fatty acids.
DR   DrugBank; DB09328; Vayarin.
DR   SwissLipids; SLP:000000368; -.
DR   GlyGen; O60427; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; O60427; -.
DR   PhosphoSitePlus; O60427; -.
DR   SwissPalm; O60427; -.
DR   BioMuta; FADS1; -.
DR   jPOST; O60427; -.
DR   MassIVE; O60427; -.
DR   PaxDb; 9606-ENSP00000322229; -.
DR   PeptideAtlas; O60427; -.
DR   ProteomicsDB; 1836; -.
DR   ProteomicsDB; 49399; -. [O60427-1]
DR   Pumba; O60427; -.
DR   Antibodypedia; 21596; 277 antibodies from 36 providers.
DR   DNASU; 3992; -.
DR   Ensembl; ENST00000433932.5; ENSP00000405087.1; ENSG00000149485.19. [O60427-2]
DR   Ensembl; ENST00000542506.5; ENSP00000441403.1; ENSG00000149485.19. [O60427-2]
DR   GeneID; 3992; -.
DR   KEGG; hsa:3992; -.
DR   UCSC; uc010rln.2; human. [O60427-1]
DR   AGR; HGNC:3574; -.
DR   CTD; 3992; -.
DR   DisGeNET; 3992; -.
DR   GeneCards; FADS1; -.
DR   HGNC; HGNC:3574; FADS1.
DR   HPA; ENSG00000149485; Low tissue specificity.
DR   MIM; 606148; gene.
DR   OpenTargets; ENSG00000149485; -.
DR   VEuPathDB; HostDB:ENSG00000149485; -.
DR   eggNOG; KOG4232; Eukaryota.
DR   GeneTree; ENSGT00950000182990; -.
DR   HOGENOM; CLU_016265_0_0_1; -.
DR   InParanoid; O60427; -.
DR   OMA; LYNCNYF; -.
DR   OrthoDB; 260091at2759; -.
DR   PAN-GO; O60427; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; O60427; -.
DR   BioCyc; MetaCyc:HS07617-MONOMER; -.
DR   BRENDA; 1.14.19.30; 2681.
DR   PathwayCommons; O60427; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   SignaLink; O60427; -.
DR   SIGNOR; O60427; -.
DR   UniPathway; UPA00658; -.
DR   BioGRID-ORCS; 3992; 20 hits in 1169 CRISPR screens.
DR   ChiTaRS; FADS1; human.
DR   GeneWiki; FADS1; -.
DR   GenomeRNAi; 3992; -.
DR   Pharos; O60427; Tchem.
DR   PRO; PR:O60427; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; O60427; protein.
DR   Bgee; ENSG00000149485; Expressed in upper leg skin and 205 other cell types or tissues.
DR   ExpressionAtlas; O60427; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0062076; F:acyl-CoA (8-3)-desaturase activity; IDA:UniProtKB.
DR   GO; GO:0016213; F:acyl-CoA 6-desaturase activity; IDA:MGI.
DR   GO; GO:0000248; F:C-5 sterol desaturase activity; TAS:ProtInc.
DR   GO; GO:0045485; F:omega-6 fatty acid desaturase activity; TAS:Reactome.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0016717; F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; IBA:GO_Central.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0007267; P:cell-cell signaling; NAS:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:UniProtKB.
DR   GO; GO:0046456; P:icosanoid biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; TAS:Reactome.
DR   GO; GO:0006629; P:lipid metabolic process; IBA:GO_Central.
DR   GO; GO:0042759; P:long-chain fatty acid biosynthetic process; IDA:MGI.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:UniProtKB.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB.
DR   CDD; cd03506; Delta6-FADS-like; 1.
DR   FunFam; 3.10.120.10:FF:000017; Fatty acid desaturase 1; 1.
DR   Gene3D; 3.10.120.10; Cytochrome b5-like heme/steroid binding domain; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR012171; Fatty_acid_desaturase.
DR   PANTHER; PTHR19353:SF57; ACYL-COA (8-3)-DESATURASE; 1.
DR   PANTHER; PTHR19353; FATTY ACID DESATURASE 2; 1.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   PIRSF; PIRSF015921; FA_sphinglp_des; 1.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; Cytochrome b5-like heme/steroid binding domain; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
DR   neXtProt; NX_O60427; -.
DR   PharmGKB; PA27973; -.
DR   TreeFam; TF313604; -.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Electron transport;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Mitochondrion;
KW   Oxidoreductase; Proteomics identification; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..444
FT                   /note="Acyl-CoA (8-3)-desaturase"
FT                   /id="PRO_0000307096"
FT   TOPO_DOM        1..121
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        122..142
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        143..145
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        146..170
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        171..267
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        268..288
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        289..305
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        306..326
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        327..444
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          17..94
FT                   /note="Cytochrome b5 heme-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   MOTIF           179..183
FT                   /note="Histidine box-1"
FT   MOTIF           216..220
FT                   /note="Histidine box-2"
FT   MOTIF           382..386
FT                   /note="Histidine box-3"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:25732826,
FT                   ECO:0007744|PubMed:22814378"
FT   VAR_SEQ         1..84
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047521"
FT   VARIANT         272
FT                   /note="P -> S (in dbSNP:rs17856235)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_035340"
FT   CONFLICT        6
FT                   /note="V -> L (in Ref. 7; AAF29378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9
FT                   /note="E -> G (in Ref. 1; BAB55103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        15
FT                   /note="P -> L (in Ref. 7; AAF29378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        100
FT                   /note="F -> L (in Ref. 1; BAC11182)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="D -> E (in Ref. 1; BAC11182)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        180
FT                   /note="D -> G (in Ref. 5; BAD96626)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="W -> R (in Ref. 1; BAB55173)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213
FT                   /note="N -> S (in Ref. 1; BAC11182)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        255
FT                   /note="K -> N (in Ref. 7; AAF29378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        319
FT                   /note="F -> L (in Ref. 1; BAB55103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        361
FT                   /note="Q -> L (in Ref. 8; AAF70457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        381
FT                   /note="F -> S (in Ref. 1; BAC11229)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410
FT                   /note="H -> R (in Ref. 8; AAF70457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="K -> E (in Ref. 1; BAC11229)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   444 AA;  51964 MW;  CC3C28D82AA49BF2 CRC64;
     MAPDPVAAET AAQGPTPRYF TWDEVAQRSG CEERWLVIDR KVYNISEFTR RHPGGSRVIS
     HYAGQDATDP FVAFHINKGL VKKYMNSLLI GELSPEQPSF EPTKNKELTD EFRELRATVE
     RMGLMKANHV FFLLYLLHIL LLDGAAWLTL WVFGTSFLPF LLCAVLLSAV QAQAGWLQHD
     FGHLSVFSTS KWNHLLHHFV IGHLKGAPAS WWNHMHFQHH AKPNCFRKDP DINMHPFFFA
     LGKILSVELG KQKKKYMPYN HQHKYFFLIG PPALLPLYFQ WYIFYFVIQR KKWVDLAWMI
     TFYVRFFLTY VPLLGLKAFL GLFFIVRFLE SNWFVWVTQM NHIPMHIDHD RNMDWVSTQL
     QATCNVHKSA FNDWFSGHLN FQIEHHLFPT MPRHNYHKVA PLVQSLCAKH GIEYQSKPLL
     SAFADIIHSL KESGQLWLDA YLHQ
//
